หมวดหมู่: CISION PR Newswire – English Feeds
-
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study
SINGAPORE, Dec. 8, 2025 First and only chemotherapy-fre…
-
TenPay Global and Mastercard collaborate to enable fast and secure remittances to Weixin Pay
SINGAPORE, Dec. 8, 2025 /PRNewswire/ — TenPay Global, …
-
Dulwich College Ranjit Murugason Sustainability Fund Secures Renewed Support from LGT Bank Singapore to Advance Student-Led Initiatives
SINGAPORE, Dec. 8, 2025 /PRNewswire/ — The Dulwich Col…
-
Global Times: Mogao Caves’ mural paintings meet modern technology
BEIJING, Dec. 8, 2025 /PRNewswire/ — The flying Apsara…
-
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 8, 2025 /PRNewswire/ — CARsgen Therapeu…
-
AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore
SINGAPORE, Dec. 8, 2025 /PRNewswire/ — ChemLex, a next…
-
RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION
SINGAPORE, Dec. 8, 2025 /PRNewswire/ — AI/ML health-te…
-
ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed
MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PR…
-
The 4th China International Supply Chain Expo Set for Beijing in June 2026
Sustained Worldwide Outreach Drives Greater Collaborati…
-
CARsgen’s CAR-T Product Zevor-Cel Included in China’s Commercial Health Insurance Innovative Drug Catalogue
SHANGHAI, Dec. 7, 2025 /PRNewswire/ — CARsgen Therapeu…